EducationHealth & FitnessMedicine

Dr. John Campbell

Campbellteaching

Hello Everyone, My name is John Campbell and I am a retired Nurse Teacher and former clinical nurse based in England. I also do some teaching in Asia and Africa when time permits. These videos are to help students to learn the background to all forms of health care. My PhD focused on the development of open learning resources for nurses nationally and internationally. LinkedIn profile, https://www.linkedin.com/in/dr-john-campbell-5256223b/ Twitter, https://twitter.com/Johnincarlisle Disclaimer; These media including videos, book, e book, articles, podcasts are not peer-reviewed. They should never replace individual clinical judgement from your own health care provider. No media-based material on this channel is suitable for using as professional medical advice. All comments are also for educational purposed only and must never replace advice from your own health care provider

Play

Open in

797 episodes
daily
Avg 24 min
English

Episodes 797

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.

October 18 · 1 hr 23 min
Standing on the shoulders of predecessors
A wide ranging discussion with Dutch journalist and author Nikko Norte. https://www.nikkonorte.com/ https://www.cavemancode.com/ https://nikkonorte.substack.com/ This video was recorded late 2023. Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 21 min
CDC, Vaccines from 6 months
C.D.C. Recommends 2 Covid Vaccines for under 5s Uploaded 19-06-22 ONS, https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/antibodies 95.9% of children aged 8 to 11 years had antibodies against SARS-CoV-2 Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children Risks of Myocarditis and Pericarditis The FDA and CDC safety surveillance systems have previously identified increased risks of myocarditis and pericarditis following vaccination with the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, particularly following the second dose. The observed risk is highest in, males 18 through 24 years of age for the Moderna males 12 through 17 years of age for the Pfizer-BioNTech COVID-19 Vaccine. most cases of myocarditis associated with the Moderna and Pfizer-BioNTech COVID-19 vaccines are characterized by rapid resolution of symptoms with no impact on quality of life reported by most patients who were contacted for follow-up at 90 days or more after reporting myocarditis. https://www.nytimes.com/live/2022/06/18/world/covid-19-mandates-vaccine-cases 19 million Moderna for ages 6 months through 5 years Pfizer-BioNTech ages 6 months through 4 years Dr. Rochelle P. Walensky, the C.D.C.’s director All children 6 months and older, including those who have already been infected with the coronavirus, should get a Covid vaccine Together, with science leading the charge, we have taken another important step forward in our nation’s fight against Covid-19 We know millions of parents and caregivers are eager to get their young children vaccinated, and with today’s decision, they can Albert Bourla, Chairman and Chief Executive Officer, Pfizer We know many parents in the U.S. have been eagerly awaiting an authorized vaccine for their children under 5 and we are proud to now offer them a vaccine option with a favorable safety profile Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-covid-19-vaccine-demonstrates-strong-immune Vaccine efficacy was 80.3% in children 6 months to under 5 years of age. N = 1,678 had 3 doses, (omicron times) This descriptive analysis was based on 10 symptomatic COVID-19 cases identified from seven days after the third dose and accrued as of April 29, 2022. (3 in the vaccine group, 7 in the placebo group) The trial protocol specifies a formal analysis will be performed when at least 21 cases have accrued from seven days after the third dose. Final vaccine efficacy data will be shared once available. Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-covid-19-vaccine-receives-fda-emergency-use MODERNA ANNOUNCES ITS COVID-19 VACCINE PHASE 2/3 STUDY IN CHILDREN 6 MONTHS TO UNDER 6 YEARS HAS SUCCESSFULLY MET ITS PRIMARY ENDPOINT https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-its-COVID-19-Vaccine-Phase-23-Study-in-Children-6-Months-to-Under-6-Years-Has-Successfully-Met-Its-Primary-Endpoint/default.aspx 6 months to 2 years, n = 2,500 enrolled 2 to under 6, n = 4,200 enrolled Rates of fever post vaccine, greater than 38 6 months to 2 years, 17% 2 years to under 6, 14.6% 6 to 12 years, 23.9% Vaccine efficacy Similar antibody response to in 18- to 25-year-olds 6 months to 2 years, 43.7% 2 to und Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 11 min
Hydroxychloroquine and ivermectin
Supressed repurposed drugs. Link to but the book, https://covidthroughoureyes.com.au/products/covid-through-our-eyes-an-australian-story-of-mistakes-mistreatment-and-misinformation Letters from Australia is Alison Bevege's Substack, https://lettersfromaustralia.substack.com/ Uploaded 21-08-25 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 15 min
POTUS, Pandemic is over
The pandemic is over (POTUS) Uploaded 21-09-22 https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines Emergency use authorizations August 31, 2022 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, and the Pfizer-BioNTech COVID-19 Vaccine, to authorize bivalent formulations, for use as a single booster dose Original strain + BA.4 and BA.5 lineages For each bivalent COVID-19 vaccine, the FDA based its decision on the totality of available evidence, including extensive safety and effectiveness data for each of the monovalent mRNA COVID-19 vaccines, safety and immunogenicity data obtained from a clinical study of a bivalent COVID-19 vaccine that contained mRNA from omicron variant BA.1 lineage that is similar to each of the vaccines being authorized, Biden administration Has already placed an order for 170 million doses https://www.science.org/content/article/omicron-booster-shots-are-coming-lots-questions Data collected by the companies Human data, only available BA.1 booster BA.1 trails did not look for protection against severe disease, (People trials are very expensive) For the BA.4/BA.5 boosters, the companies have submitted animal data. (not released publicly) Pfizer presented preliminary findings in eight mice given BA.4/BA.5 vaccines as their third dose, (for EMA) Showed an increased antibody response to all Omicron variants tested: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Clinical trials for the BA.4/BA.5 vaccines will begin this month August 19, 2022 https://www.fda.gov/news-events/press-announcements/fda-roundup-august-19-2022 Today, the FDA authorized the emergency use of Novavax COVID-19 Vaccine, in individuals 12 through 17 years of age. This authorization follows a rigorous analysis and evaluation of the safety and effectiveness data conducted by the FDA. July 13, 2022 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, in individuals 18 years of age and older. June 17, 2022 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children Today, the U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, in children down to 6 months of age. December 22, 2021 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 18 min
Excess deaths in 2023
Excess deaths by week, 2023 Uploaded 27-11-23 https://data-explorer.oecd.org https://stats.oecd.org/index.aspx?queryid=104676 Australia, weeks 1 – 34, 2023 14,710 (16.8%) Covid deaths, 4,977 Australia, 2022, weeks 1 - 52 29,738 (18.7%) Australia, excess deaths 2022 + 2023 = 44,448 Austria, week 1 – 44, 2023 4,444 (6.5%) Canada, weeks 1 – 33, 2023 28,400 (16.7%) Covid deaths, 4,613 Canada, 2022 61,468 (22.3%) Canada, excess deaths 2022 + 2023 = 89,868 Denmark, weeks 1 – 44, 2023 3,052 (6.9%) Covid deaths, 347 Denmark, 2022 5,871 (11%) Denmark, excess deaths 2022 + 2023 = 8,923 Finland, weeks 1 – 44, 2023 4,627 (10.5%) France, weeks 1 – 44, 2023 22,268 (4.9%) Covid deaths, 5,565 France, 2022 71,751 (11.9%) Germany, weeks 1 – 44, 2023 59,039 (7.7%) Germany, 2022 134, 578 (14.9%) Greece, weeks 1 – 44, 2023 5,132 (5.2%) Iceland, weeks 1 – 44, 2023 209 (11.5%) Covid deaths, 0 Iceland, 2022 446 (20.2%) Israel, weeks 1 – 44, 2023 4,303 (11.8%) Covid deaths, 640 Israel, 2022 7,050 (15.4%) Italy, weeks 1 – 44, 2023 938 (0.28%) Netherlands, weeks 1 – 44, 2023 14,209 (11.3%) Netherlands, 2022 19,326 (13.2%) New Zealand, weeks, 1 – 44, 2023 3,960 (14.5%) New Zealand, 2022 5,787 (17.6%) Norway, weeks 1 – 44, 2023 1,885 (5.7%) Norway, 2022 4,980 (12.5%) Portugal, weeks 1 – 44, 2023 5,184 (6.3%) Spain, weeks 1 – 44, 2023 11,948 (3.7%) Switzerland, 1 – 44, 2023 2,063 (3.9%) UK, weeks 1 – 44, 2023 49,389 (9.44%) Covid deaths, 18,591 UK, 2022 52,514 (9.26%) UK excess deaths 2022 + 2023 = 101,903 Height of the Blitz, September 1940 to May 1941 UK civilian deaths, 40,000 Total civilian deaths for WW2, 70,000 US, weeks 1 – 37, 2023 155,763 (7.8%) Covid deaths, 76,187 US, 2022 495,749 (17.53) US excess deaths 2022 + 2023 = 651,512 Total US deaths in Vietnam war The U.S. National Archives shows that 58,220 U.S. soldiers perished. https://www.worldatlas.com/articles/how-many-americans-were-killed-in-the-vietnam-war.html Hungary, weeks 1 – 44, 2023 -3,785 (-3.2%) Poland, weeks 1 – 43, 2023 104 (0.13%) Slovak republic, weeks 1 – 43, 2023 -774 (-1.54%) Sweden, weeks 1 – 44, 2023 -529 (0.6%) Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 26 min
Highest deaths since 1929
but they are now going down. Uploaded 26-05-22 US omicron variants https://covid.cdc.gov/covid-data-tracker/#variant-proportions BA.2, 39% BA.2.12.1, 58% Less common omicron derivatives Others, 0.1% Delta, 0% UK, covid symptom Zoe study ONS https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections Risk of re-infection Risk of re-infection, eight times higher in Omicron times (20 December 2021 onwards), compared with Delta times, (17 May to 19 December 2021) Deaths COVID-19 is mentioned on fewer death certificates than flu and pneumonia But, more likely to be listed as the underlying cause of death Number of deaths due to COVID-19, and flu and pneumonia, England and Wales, 1901 to 2021 COVID-19, 2020 Underlying cause of 73,766 deaths COVID-19, 2021 Underlying cause of 67,258 deaths Deaths due to flu and pneumonia, 1929 Underlying cause of 73,212 deaths Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 2 min
First clause, Nuremberg Code 1947
Nuremberg Code (1947)full video, https://www.youtube.com/watch?v=_oZAPk_Xpow Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 1 hr 30 min
Cheap repurposed drug
Professor of Oncology, Angus Dalgleish gives vital information on a repurposed drug he uses for his cancer patients, given at a very low dose. This is Low Dose Naltrexone. Uploaded 03-05-25 Check out the LDN trust website for much more, https://ldnresearchtrust.org Naltrexone at low doses (LDN) and its relevance to cancer therapy https://openaccess.sgul.ac.uk/id/eprint/114135/ Naltrexone was designed to inhibit opioid receptors without activating them and hence used to block the stimulatory effects of morphine and heroin. It was noted that in certain patients being treated with naltrexone for an opioid addiction many reported significant secondary benefit when being weaned off naltrexone. This group of patients had chronic inflammatory and autoimmune conditions and reported improvements whilst using the lower dosages of naltrexone. There have also been recent anecdotal reports of cancer resolution following the use of low doses of naltrexone (LDN). However, the mechanism of action is unclear. Areas covered We review three mechanisms through which LDN can influence cancer progression; namely, (a) antagonism of receptors to which LDN binds, which include toll-like receptors 7–9 that lead to IL-6 suppression b) modulation of immune function in patients; and c) direct inhibition of signaling pathways involved in cancer cell control, including the priming of pro-apoptotic pathways. Expert opinion Considering the increase in the number of anecdotal reports of activity, there will likely be a bigger drive toward using LDN in the oncological setting. These reports support clinical trials of LDN in cancer, especially when given in combination with certain chemotherapy. https://ldnresearchtrust.org/angus-dalgleish-md-role-ldn-management-cancer-2018-conference-ldn-low-dose-naltrexone Major clinical evidence on the use of low-dose naltrexone in the treatment of cancer: a systematic review https://www.researchgate.net/publication/384236060_Major_clinical_evidence_on_the_use_of_low-dose_naltrexone_in_the_treatment_of_cancer_a_systematic_review https://www.tandfonline.com/doi/full/10.1080/14737140.2022.2037426#abstract Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 10 min
Professor Anderson, geomanipulation and vaccines
More valuable insights from doctor, endocrinologist, author, medical researcher and teacher, professor David Anderson. Link to order or download, Vitamin D and the Great Biology Reset, https://dgreatbiologyreset.com/ Uploaded 16-05-25 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 17 min
Omicron science, promising news
New science explains South Africa's low rates of omicron severe disease SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron https://www.medrxiv.org/content/10.1101/2021.12.26.21268380v1 https://www.medrxiv.org/content/10.1101/2021.12.27.21268278v1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations These contribute to escape from the neutralizing antibody responses, reducing vaccine protection from infection We assessed the ability of T cells to react with Omicron spike In participants who were vaccinated with Ad26.CoV2.S (J and J) (n = 20) or BNT162b2 (Pfizer) (n = 15 or in unvaccinated convalescent COVID-19 patients (n = 15) SARS-CoV-2-specific T cells play a key role in modulating COVID-19 severity and provide protective immunity Results 70-80% of the CD4 and CD8 T cell response to spike was maintained across study groups The magnitude of Omicron cross-reactive T cells was similar to that of the Beta and Delta variants These results demonstrate that, despite Omicron’s extensive mutations and reduced susceptibility to neutralizing antibodies, the majority of T cell response, induced by vaccination or natural infection, cross- recognises the variant. Well-preserved T cell immunity to Omicron, is likely to contribute to protection from severe COVID-19, supporting early clinical observations from South Africa. Further explanation The limited effect of Omicron’s mutations on the T cell response suggests that vaccination or prior infection may still provide substantial protection from severe disease. Indeed, South Africa has reported a lower risk of hospitalisation and severe disease compared to the previous Delta wave Cross-reactive T cell responses acquired through vaccination or infection may contribute to these apparent milder outcomes for Omicron. The resilience of the T cell response demonstrated here also bodes well in the event that more highly mutated variants emerge in the future. Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 2 min
D and K2 together
Link to whole video, https://www.youtube.com/watch?v=0Ken0luasu0 Free download John’s textbooks in high res pdf. https://drjohncampbell.co.uk Order my Physiology Notes in hard copy if you live in the UK, https://www.ebay.co.uk/itm/154973392319?mkcid=16&mkevt=1&mkrid=711-127632-2357-0&ssspo=K6raxMZrQnm&sssrc=2047675&ssuid=&widget_ver=artemis&media=EMAIL Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 24 min
Everyone was susceptible
COVID, the untold story. So much more makes sense after this book and my first illuminating discussion with Dr. Craig. Get your copy in the UK here: https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707 Uploaded 28-11-23 For friends in the US get your copy here, https://www.amazon.com/Expired-untold-Dr-Clare-Craig/dp/1739344707 Have you ever felt the covid story did not entirely add up? Expired contains multiple eye-opening revelations about covid with compelling evidence that provides a coherent, sober and clear explanation that better fits the data we have so far. Meticulous research by pathologist Dr Clare Craig sheds light on the largely overlooked evidence of airborne virus transmission, examining twelve related beliefs on spread, lockdowns, asymptomatic infections, and masks. In addition, Expired champions the importance of Western ethical principles, damaged by pandemic actions and calls for their restoration. The covid debate has proved incredibly polarising. One side believed every intervention was saving lives, while the other emphasised the harms caused. Biased modelling based on a worst-case scenario led to fearful assumptions presented as fact. By dint of sheer repetition these ‘facts’ became unquestionable. Those scientists who dared to question were proclaimed dangerous. Welcome to Cloud-Covid-Land. Let’s bring back nuance. It’s time to return to reality." Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 11 min
Trip to Davos
With Consultant Cardiologist, Dr. Aseem Malhotra, Uploaded 22-08-25 First do on Pharm, https://nopharmfilm.com/ https://www.imdb.com/title/tt33511587/ Aseem's work site, https://draseemmalhotra.co.uk/ Hope Accord link, https://thehopeaccord.org http://drjohncampbell.co.uk/C.mp4 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 9 min
What is a jab
Third part of this excellent talk with Professor Robert Clancy, doctor, immunologist, consultant physician, professor of pathology and professor of medicine, highly published medical researcher, author, teacher, doctor of science, doctor of philosophy, holder of the Australia Medal. Link to buy the book, https://covidthroughoureyes.com.au/products/covid-through-our-eyes-an-australian-story-of-mistakes-mistreatment-and-misinformation Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 19 min
Who fact checks the fact checkers
Now all of the facts were equal, but some facts were more equal than others. Uploaded 10-10-22 Institute for Scientific Freedom https://www.scientificfreedom.dk/strategy/?utm_source=substack&utm_medium=email 1 All science should strive to be free from financial conflicts of interest. 2 All science should be published as soon as possible and made freely accessible. 3 All scientific data, including study protocols, should be freely accessible, allowing others to do their own analyses. Open letter from BMJ to Facebook about inappropriate censoring of serious data integrity issues in Pfizer’s COVID-19 vaccine trial https://www.scientificfreedom.dk/2021/12/18/open-letter-from-bmj-to-facebook-about-inappropriate-censoring-of-serious-data-integrity-issues-in-pfizers-covid-19-vaccine-trial/ https://www.bmj.com/content/375/bmj.n2635/rr-80 Fiona Godlee, editor in chief Kamran Abbasi, incoming editor in chief The BMJ Competing interests: As current and incoming editors in chief, we are responsible for everything The BMJ contains. Dear Mark Zuckerberg, The BMJ, one of the world’s oldest and most influential general medical journals. https://www.bmj.com/about-bmj/history-of-the-bmj 3rd October 1840 Serious concerns about the “fact checking” being undertaken by third party providers on behalf of Facebook/Meta. In September, a former employee of Ventavia, a contract research company helping carry out the main Pfizer covid-19 vaccine trial, began providing The BMJ with dozens of internal company documents, photos, audio recordings, and emails. These materials revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety. We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA did not inspect Ventavia’s trial sites. The BMJ commissioned an investigative reporter to write up the story for our journal. The article was published on 2 November, (2021) following legal review, external peer review and subject to The BMJ’s usual high level editorial oversight and review. Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial https://www.bmj.com/content/375/bmj.n2635 But from November 10, readers began reporting a variety of problems when trying to share our article. Some reported being unable to share it. Many others reported having their posts flagged with a warning about “Missing context … Independent fact-checkers say this information could mislead people.” Those trying to post the article were informed by Facebook that people who repeatedly share “false information” might have their posts moved lower in Facebook’s News Feed. Group administrators where the article was shared received messages from Facebook informing them that such posts were “partly false.” Readers were directed to a “fact check” performed by a Facebook contractor named Lead Stories. Fact Check: The British Medical Journal Did NOT Reveal Disqualifying And Ignored Reports Of Flaws In Pfizer COVID-19 Vaccine Trials https://leadstories.com/hoax-alert/2021/11/fact-check-british-medical-journal-did-not-reveal-disqualifying-and-ignored-reports-of-flaws-in-pfizer-vaccine-trial.html We find the “fact check” performed by Lead Stories to be inaccurate, incompetent and irresponsible. – It fails to provide any assertions of fact that The BMJ article got wrong – It has a nonsensical title: “Fact Check: The British Medical Journal Did NOT Reveal Disqualifying And Ignored Reports Of Flaws In Pfizer COVID-19 Vaccine Trials” – The first paragraph inaccurately labels The BMJ a “news blog” – It contains a screenshot of our article with a stamp over it stating “Flaws Reviewed,” despite the Lead Stories article not identifying anything false or untrue in The BMJ article – It published the story on its Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 24 min
Childhood hepatitis outbreaks
In the UK, US and Europe If you would like John’s text books, (it is free to download the PDFs), use this link, http://159.69.48.3/ Uploaded 17-04-22 Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland https://www.who.int/emergencies/disease-outbreak-news/item/acute-hepatitis-of-unknown-aetiology---the-united-kingdom-of-great-britain-and-northern-ireland WHO monitoring cases of hepatitis in children across UK Children up to 10 years Hepatitis viruses (A, B, C, E, D), excluded Six had liver transplants Scotland, 10 cases of severe acute hepatitis in children Scotland, 13 cases reported Rest of the UK, 74 cases England, 49 Wales and NI, 12 Ireland, 5 Spain, 3 (22-month-old to 13-year-old) Denmark Netherlands ECDC (European Centre for Disease Prevention and Control) https://www.euronews.com/next/2022/04/15/europe-on-alert-as-uk-investigates-mysterious-cases-of-severe-hepatitis-in-young-children Jaundice, vomiting, stomach problems muscle and joint pain fever nausea tired all the time general sense of feeling unwell loss of appetite localised pain dark urine pale, grey-coloured poo itchy Alabama https://www.medscape.com/viewarticle/972272 Cases, 9 Between 1 and 6 years old 2 liver transplants No epidemiological links so far Adenovirus 41 About half have tested positive No viral genetics as yet Known to cause hepatitis in immunocompromised More cases expected to report As of 11th April No hepatitis deaths recorded One epidemiologically linked case detected (patient contact with a sufferer or point source of infection) Dr Meera Chand, director of clinical and emerging infections, UK Health Security Agency investigate a wide range of possible factors which may be causing children to be admitted to hospital with liver inflammation known as hepatitis One of the possible causes that we are investigating is that this is linked to adenovirus infection However, we are thoroughly investigating other potential causes SARS-CoV-2 detected in several cases Officials stressed no link Covid-19 vaccine none of the children affected by hepatitis had received a jab Wating for Infections, chemicals, toxins Dr Chand Normal hygiene measures such as good handwashing, including supervising children, and respiratory hygiene, help to reduce the spread of many of the infections that we are investigating. We are also calling on parents and guardians to be alert to the signs of hepatitis, including jaundice, and to contact a healthcare professional if they are concerned Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 58 min
Shroud, Biblical and historic aspects
Links for Rich, YouTube videos: "Biblical Mysteries Explained" https://www.youtube.com/@BiblicalMysteriesExplained Uploaded 29-06-25 Article sites: academia.edu, researchgate.net, richardsorensen.com, unholygrail.net/blog Watch this excellent film from David Rolfe, https://whocanhebe.com/Stream.html Watch this excellent film from David Rolfe, https://whocanhebe.com/Stream.html Link to download my PowerPoint, https://drjohncampbell.co.uk/ Shroud.com https://www.shroud.com/menu.htm Shroudphotos.com https://shroudphotos.com 3D Image https://shroud3d.com/introduction/3d-studies-of-the-shroud-of-turin-history/ Shroud fabric https://www.shroud.com/pdfs/ssi3233part3.pdf 3D reconstruction https://www.shroud.com/pdfs/ssi3233part3.pdf STURP conclusions https://www.shroud.com/78conclu.htm Study on radiocarbon result https://www.sciencedirect.com/science/article/abs/pii/S0040603104004745 New dating study on X ray scattering https://www.mdpi.com/2571-9408/5/2/47 Polon studies https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:210758-1 1. ca. 33 Jesus is crucified and buried by Nicodemus and Joseph of Arimathea, with burial cloth and tomb provided by the latter. Then Jesus rises from the dead. When the disciples enter the empty tomb, they see the burial cloths according to the Gospels. 2. ca 33-38 The burial cloth of Christ was said to be brought to Edessa by Thomas or Thaddeus at the request of King Abgar V of Edessa, who was miraculously healed. Edessa becomes a Christian city. A mosaic tile was made of face on the Shroud, known as the Keramion, and placed over the city gate. In addition to the Shroud, this tile may have been the model used for future pictures of Christ. 3. 57 Ma’nu VI becomes king of Edessa and reverts the city to paganism. The Shroud and the Keramion are hidden in the city walls to protect them from destruction, and the location was apparently forgotten. 4. 525 The Shroud and the Keramion are rediscovered during the rebuilding of Edessa after a flood. 5. 544 Edessa is besieged by a Persian army and the Shroud and/or the Keramion purportedly save the city. Following this, the Hagia Sophia church (named after its analog in Constantinople) is constructed to house and venerate the Shroud and the Keramion. The Shroud is shown to the public every Easter, but in an air of secrecy and mystery. In this era the appearance of Christ as depicted in Christian art suddenly changes from a smooth Greco-Roman style to a Semitic man, with the characteristics of the face from the Shroud and/or the Keramion. Syriac artists become the main source of Christian art. 6. 944 - 1204 The Byzantine emperor, Romanus Lacapenus sends an army to Edessa to capture the Shroud and bring it to Constantinople as a means of divine protection. The Shroud was received with great ceremony and paraded through the city – a copy of the sermon given by on that occasion still exists. The Shroud is kept in the imperial relic treasury and periodically presented to private audiences. 7. 1204 The knights of the 4th Crusade come to Constantinople, supposedly on their way to Jerusalem, but due to a complex and unfortunate series of political events, they sack Constantinople instead. The Shroud is taken by the crusaders. 8. 1204 – 1355 This period is known as the “missing years” of the Shroud. The explanation with the most documentary evidence is that the Shroud was given to or taken by the knight Othon de la Roche, a knight from the Burgundy region of France who became the Lord of Athens in Greece. The Shroud may have been in Greece but was eventually brought to Besançon, the capital of Burgundy. In any case the Shroud eventually became the property of Geoffrey de Charny and his family. Geoffrey de Charny, a Templar and high counselor to King John II of France, and the Lord of Lirey and Savoisy in France, had built a chapel in Lirey to commemorate his res Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 1 hr 19 min
Outstanding podcast with Hearts of Oak
Original link, https://www.youtube.com/watch?v=YkRg5dyvGPE&t=2735s Check out Hearts of Oak, for some great talks, https://www.youtube.com/@UCy7r6GYTGA1gpHEZfqnscQA Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 25 min
New treatment for depression
Boom in psychedelic therapies? Uploaded 23-08-22 https://www.telegraph.co.uk/news/2022/08/20/magic-mushrooms-set-become-uks-ultimate-weapon-against-depression/ https://www.theguardian.com/science/2022/apr/12/psilocybin-depression-brain-break-out-of-a-rut-magic-mushrooms Short-acting drugs, psychedelic experience, two-hour therapy session. Resetting brain networks Helping to end ingrained negative patterns of thought, and making patients far more receptive to therapy. Small Pharma https://smallpharma.com Leading the world’s first regulated clinical trial, DMT (dimethyltryptamine) with psychotherapy for major depressive disorder. Phase one done on healthy volunteers Next few months, reports from 42 patients Dr Carol Routledge, chief medical and scientific officer We think that this treatment will really get to the root cause, rather than just dampening symptoms Almost immediate benefits Based on initial data that we already have, and other companies have, there’s going to be a fairly immediate impact In terms of the psychedelic experience, we’re talking about 20 minutes, and then the integration therapy afterwards, we expect the antidepressant activity to be extremely durable … to last maybe three, four or five months Imaging data Psychedelics work on the brain networks Making neural connections more flexible to brain plasticity You can reset those networks in the brain, and then that leaves the brain much more receptive to therapy, which is why we bring it in straight afterwards Medicines and Healthcare products Regulatory Agency (MHRA) Innovative Licensing and Access Pathway (ILAP) Brings organisations together Speed up the time getting meds to patients Other companies testing MDMA 3,4-Methylenedioxymethamphetamine Therapy for post-traumatic stress disorder (PTSD) Psilocybin, (Clerkenwell Health) Depression Smoking Terminal illness Psychedelic experience Out-of-body sensations Visual or aural hallucinations Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls https://www.nature.com/articles/s41598-022-14512-3#Tab2 University of British Columbia, Vancouver, July, 2022 Psilocybin microdosing Repeated self-administration of mushrooms containing psilocybin, at doses small enough to not impact regular functioning. 3–5 times per week, of 0.1 to 0.3 g of dried mushrooms Naturalistic, observational design Study approved, University of British Columbia Research Ethics Board (H19-03051) Psilocybin microdosers (n = 953) Non-microdosing comparators (n = 180) For approximately 30 days Identified small- to medium-sized improvements in mood and mental health, that were generally consistent across gender, age and presence of mental health concerns Improved psychomotor performance in older adults. Depression, Anxiety and Stress Scale https://proceduresonline.com/trixcms2/media/11957/depression-anxiety-and-stress-scale-dass21.pdf Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers https://www.nature.com/articles/s41598-021-01811-4 Large international sample of adults microdosers (n = 4050) non-microdosers (n = 4653) Psilocybin, 85% of microdosers, (LSD, 11%) microdosers exhibited lower levels of depression, anxiety, and stress across gender microdosers were less likely to use alcohol regularly and were more likely to abstain from alcohol entirely microdosers were more likely to abstain from the use of nicotine Psilocybin, in 10mg or 25mg doses, has no short- or long-term detrimental effects in healthy people https://www.kcl.ac.uk/news/psilocybin-in-10mg-or-25mg-doses-has-no-short-or-long-term-detrimental-effects-in-healthy-people https://journals.sagepub.com/doi/full/10.1177/02698811211064720 The therape Learn more about your ad choices. Visit megaphone.fm/adchoices
October 18 · 20 min
FDA full approval for Pfizer
FDA Approves First COVID-19 Vaccine Uploaded 24-08-21 EUA since December 11, 2020 https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine U.S. Food and Drug Administration Pfizer-BioNTech COVID-19 Vaccine Will now be marketed as Comirnaty (koe-mir’-na-tee) for the prevention of COVID-19 disease in individuals 16 years of age and older Continues to be available under emergency use authorization (EUA), 12 to 15s and for a third dose in immunocompromise Acting FDA Commissioner Janet Woodcock, M.D While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S. FDA statement The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into - nor does it alter - an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart. Analyzed effectiveness and safety data from 20,000 vaccine and 20,000 placebo recipients Vaccine was 91% effective in preventing COVID-19 disease Safety, approximately 12,000 recipients have been followed for at least 6 months. The most commonly reported side effects Pain, redness and swelling at the injection site Fatigue, headache, muscle or joint pain, chills, and fever Rigorous evaluation of the post-authorization safety surveillance data Myocarditis and pericarditis Chest pain, shortness of breath, or feelings of having a fast-beating, fluttering, or pounding heart https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-june-25-2021 https://www.cdc.gov/mmwr/volumes/70/wr/mm7027e2.htm 52 million doses to 12–29 years 1,226 reports of myocarditis after mRNA vaccination 42,414 One in 42,414 Data demonstrate increased risks, particularly within the seven days following the second dose The observed risk is higher among males under 40 years of age compared to females and older males Risk is highest in males 12 through 17 years of age Short-term follow-up suggest that most individuals have had resolution of symptoms Some individuals required intensive care support Information is not yet available about potential long-term health outcomes FDA and CDC, monitoring systems in place for early detection Pfizer will Conduct postmarketing studies to further assess the risks of myocarditis and pericarditis Include an evaluation of long-term outcomes Conducting a pregnancy registry study to evaluate pregnancy and infant outcomes after vaccination during pregnancy Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Showing 361–380 of 797 episodes